HAART is effective as anti-Kaposi's sarcoma therapy only after remission has been induced by chemotherapy

被引：0
|
作者：
Vaccher, E [1 ]
di Gennaro, G [1 ]
Nasti, G [1 ]
Juzbasic, S [1 ]
Tirelli, U [1 ]
机构：
[1] Natl Canc Inst, GICA, Div Med Oncol A, Ctr Riferimento Oncol, Aviano, Italy
来源：
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 1999年 / 22卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：407 / 408
页数：2
相关论文
共 10 条
  • [1] Highly active antiretroviral therapy (HAART) is active as anti-Kaposi's sarcoma (KS) therapy: Results of a trial in 53 patients (PTS)
    Vaccher, E
    Maserati, R
    Mongiovetti, M
    Nasti, G
    Fasan, M
    Vigan, MG
    Bottura, P
    Mena, M
    Pan, A
    Demichieli, A
    Chieppa, F
    Bertelli, D
    Accurso, V
    Di Gennaro, GP
    Schioppa, O
    Tirelli, U
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (03) : A22 - A22
  • [2] Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy
    V Martinez
    E Caumes
    L Gambotti
    H Ittah
    J-P Morini
    J Deleuze
    I Gorin
    C Katlama
    F Bricaire
    N Dupin
    [J]. British Journal of Cancer, 2006, 94 : 1000 - 1006
  • [3] Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy
    Martinez, V
    Caumes, E
    Gambotti, L
    Ittah, H
    Morini, JP
    Deleuze, J
    Gorin, I
    Katlama, C
    Bricaire, F
    Dupin, N
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (07) : 1000 - 1006
  • [4] Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma
    Bower, M
    Fox, P
    Fife, K
    Gill, J
    Nelson, M
    Gazzard, B
    [J]. AIDS, 1999, 13 (15) : 2105 - 2111
  • [5] Treatment of HIV-1-Associated Kaposi’s Sarcoma with Pegylated Liposomal Doxorubicin and HAART Simultaneously Induces Effective Tumor Remission and CD4+ T Cell Recovery
    M. Lichterfeld
    N. Qurishi
    C. Hoffmann
    B. Hochdorfer
    N. H. Brockmeyer
    K. Arasteh
    S. Mauss
    J. K. Rockstroh
    [J]. Infection, 2005, 33 : 140 - 147
  • [6] Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+T cell recovery
    Lichterfeld, M
    Ourishi, N
    Hoffmann, C
    Hochdorfer, B
    Brockmeyer, NH
    Arasteh, K
    Mauss, S
    Rockstroh, JK
    [J]. INFECTION, 2005, 33 (03) : 140 - 147
  • [7] Development of Kaposi’s sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient
    Alastair B. Law
    Gail Ryan
    Stephen Lade
    H. Miles Prince
    [J]. International Journal of Hematology, 2010, 91 : 347 - 348
  • [8] Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient
    Law, Alastair B.
    Ryan, Gail
    Lade, Stephen
    Prince, H. Miles
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (02) : 347 - 348
  • [9] Complete remission of AIDS-related Kaposi's sarcoma associated with undetectable human herpesvirus-8 sequences during anti-HIV protease therapy
    Blum, L
    Pellet, C
    Agbalika, F
    Blanchard, G
    Morel, P
    Calvo, F
    Lebbe, C
    [J]. AIDS, 1997, 11 (13) : 1653 - 1655
  • [10] Case report: Sustained remission after combined sintilimab, anti-VEGF therapy, and chemotherapy in a patient with non-small cell lung cancer harboring acquired EGFR 19Del/T790M/cis-C797S mutation resistance
    He, Wanming
    Tong, Lihua
    Yang, Wen
    Yuan, Yanling
    Li, Yu
    Tang, Wubing
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
1